|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 37/18 | |
| A61P 5/00 | |||
| A61K 38/30 |
| (11) | Number of the document | 2274978 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10009976.1 |
| Date of filing the European patent application | 2004-09-09 | |
| (97) | Date of publication of the European application | 2011-01-19 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 502579 P | 2003-09-12 | US |
| (72) |
Clark, Ross G., NZ
|
| (73) |
Ipsen Biopharmaceuticals, Inc.,
106 Allen Road, 3rd Floor, Basking Ridge, NJ 07920,
US
|
| (54) | Methods for treatment of insulin-like growth factor-I(IGF-I) deficiency |
| Methods for treatment of insulin-like growth factor-I(IGF-I) deficiency |